Detalhe da pesquisa
1.
Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study.
Lancet Oncol
; 25(2): 212-224, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38134948
2.
Tumor Response Predicts Survival Time of Nivolumab Monotherapy for Advanced Gastric Cancer: A Subgroup Analysis of the DELIVER Trial (JACCRO GC-08).
Oncologist
; 2024 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38581687
3.
Trastuzumab deruxtecan in patients with locally advanced or metastatic HER2-positive gastric cancer: a multicenter, open-label, expanded-access study.
Int J Clin Oncol
; 29(1): 27-35, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37964066
4.
First-line pembrolizumab plus chemotherapy for advanced/metastatic esophageal cancer: 1-year extended follow-up in the Japanese subgroup of the phase 3 KEYNOTE-590 study.
Esophagus
; 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38607538
5.
Inflammatory prognostic factors in advanced or recurrent esophageal squamous cell carcinoma treated with nivolumab.
Cancer Immunol Immunother
; 72(2): 427-435, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35927359
6.
Nivolumab versus irinotecan as third- or later-line treatment for advanced gastric cancer: a multi-center retrospective study.
Int J Clin Oncol
; 28(6): 756-763, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36943545
7.
Phase II clinical trial to study the safety and efficacy of combined S-1 + oxaliplatin therapy as neoadjuvant chemotherapy for locally advanced gastric cancer in older patients.
Int J Clin Oncol
; 28(9): 1166-1175, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37368093
8.
Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 23(2): 234-247, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35030335
9.
Phase IIb study of pembrolizumab combined with S-1 + oxaliplatin or S-1 + cisplatin as first-line chemotherapy for gastric cancer.
Cancer Sci
; 113(8): 2814-2827, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35701865
10.
Real-world effectiveness of nivolumab in advanced gastric cancer: the DELIVER trial (JACCRO GC-08).
Gastric Cancer
; 25(1): 235-244, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34427838
11.
Prospective analysis of the expression status of FGFR2 and HER2 in colorectal and gastric cancer populations: DS-Screen Study.
Int J Colorectal Dis
; 37(6): 1393-1402, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35585358
12.
Real-world effectiveness of third- or later-line treatment in Japanese patients with HER2-positive, unresectable, recurrent or metastatic gastric cancer: a retrospective observational study.
Int J Clin Oncol
; 27(7): 1154-1163, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35489010
13.
Primary tumor location as a predictor of survival in patients with RAS wild-type colorectal cancer who receive molecularly targeted drugs as first-line therapy: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum.
Int J Clin Oncol
; 27(9): 1450-1458, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35861943
14.
First-line pembrolizumab + chemotherapy in Japanese patients with advanced/metastatic esophageal cancer from KEYNOTE-590.
Esophagus
; 19(4): 683-692, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35668304
15.
Hepatectomy Followed by Adjuvant Chemotherapy with 3-Month Capecitabine Plus Oxaliplatin for Colorectal Cancer Liver Metastases.
Oncologist
; 26(7): e1125-e1132, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33977607
16.
Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japan.
BMC Cancer
; 21(1): 518, 2021 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33962575
17.
Associated characteristics and treatment outcomes of medication-related osteonecrosis of the jaw in patients receiving denosumab or zoledronic acid for bone metastases.
Support Care Cancer
; 29(8): 4763-4772, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33527228
18.
Phase Ib/II Study of Biweekly TAS-102 in Combination with Bevacizumab for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies (BiTS Study).
Oncologist
; 25(12): e1855-e1863, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32666647
19.
A simplified method for therapeutic drug monitoring of mitotane by gas chromatography-electron ionization-mass spectrometry.
Biomed Chromatogr
; 34(3): e4776, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31826297
20.
Sex differences in the safety of S-1 plus oxaliplatin and S-1 plus cisplatin for patients with metastatic gastric cancer.
Cancer Sci
; 110(9): 2875-2883, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31254422